chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the day of the vaccine had no problems, this morning 2/4/21 started to have itching, redness at the vaccine site, as well as swelling.  The swelling was hard in nature.  Also has had diarrhea and vomiting at 2:00 Am this morning.  Got really hot and cold sweaty feel, then turning to chills.  Stomach hurting, breathing was labored, trying to stay calm.  Finally the diarrhea ran it's course, went back to bed and is very sore all over, especially her arms and shoulders to the point she can hardly use them.  She is now noticing pain in her arms and legs, just hurts all over.    Yesterday she took Tylenol before bed, has not taken anything today.   The vaccine site is still itchy, red, and swollen in a hard way and hurts.
presented to local ED lethargic, disoriented and unable to provide clear history on evening of 5/1/21 with severe frontal headache and increasing lethargy throughout the day.  Admitted to hospital with suspected subacute stroke.  Overnight developed LT sided weakness and RT gaze.  Transferred to another healthcare facility on 5/3/21 with suspected seizure / encephalitis.
Headache, high fevers, chills, aches, and pains (all were severe) for two days. Fatigue.  Loss of appetite.
Patient got a pimple the day after vaccine. Redness in both cheeks a few days after first dose of the vaccine. No swelling of tongue or face. No shortness of breath. On occasion without known precipitant, she has had swelling of the uvula. One time with ammonia exposure had swelling of her uvula. She has epi pen and Benadryl and is very competent. This is her second vaccine and no anaphylaxis after the first. No swelling of uvula. Will continue with vaccination and observe for 30 minutes.
4 days after vaccination, developed isolated RIGHT preauricular adenopathy. No other problems. No ear pain, sore throat, fever, or other evidence of URI. Has happened once before in entire life, and that was with fever and sore throat.  After 16 hours of swelling and mild aching from swollen nodes, consumed Naprosyn 250mg 12 hours apart. 2 doses total. awoke the next morning with isolated, painless, 2 cm bullae on left abdomen, 3 cm bullae on left forearm, 1 cm reddened patch adjacent to arm bullae (suspected this area to also develop bullae). Discontinued Naprosyn. Abdominal bullae spontaneously drained. Reddened patch disappeared. 3 cm bullae persists but no growth or change. No new lesions, though right preauricular adenopathy slightly increased in swelling and tenderness.
I started feeling mild symptoms on Friday, I contacted my doctor because I had been exposed to COVID. I went in for a PCR test. On Saturday, I felt much worse. I had headaches, body aches, runny nose, sneezing. It felt like the worse cold you could ever have. On Sunday, the test came back positive. I was prescribed Paxlovid which has helped. On Tuesday, I started experiencing dizziness and nausea. I have been prescribed Meclizine to help me with both the nausea and dizziness.
Patient had adverse reaction in back of the arm containing redness, swelling and tenderness. Appears vaccination may have been administered subcutaneously instead of intramuscularly.
Patient states she developed soreness from right side of neck, down entire length of arm with considerable muscular tenderness in right arm and without erythema, warmth or drainage at injection site, the day of/after the vaccine. On second day following immunization, patient continued to have myalgias in entire body and presented to clinic. Patient had 4" in diameter localized reaction at injection site which was red and warm. Patient did not present with fever or any other symptoms at that time. Per CDC, although rare, these sx can be associated with this particular vaccine. Advised patient would follow up with VAERS, explained this system to patient and had patient treat sx with NSAIDs, acetaminophen and ice. Patient to call clinic if any change or worsening sx. Discussed s/sx of infection with patient and any emergent s/sx.
Fever of 101-102 degrees F started and lasted 5 days total. Head to toes redness started and lasted 5 days total. Patient out of school for fever for 3 days total 08/20/2018-08/22/2018.
Have had a mild to moderate headache that started just after 24 hours after 2nd shot. It has now lasted 10 days. Mornings are usually a little better, but head still feels cloudy. Over the counter pain relievers do not really help very much. Now have also had chest tightness for the last three days. I have no history of ever having headaches, maybe one per year previously.
Systemic: Nausea-Medium, Systemic: Seizure-Severe, Additional Details: Patient received vaccine and within 2 minutes complained of nausea& lightheadedness to his mother then passed out. Upon putting him on the ground he began to seize. Paramedics called & came & took vitals. All within normal limits. Patient was alert & talking & stated he felt fine. Upon being sat up in a chair his eyes rolled back & he began to seize again, more violently. He was then placed on strecher & taking to ER.
Excoriated urticarial pruritic lesion R deltoid (inj site) after injection and lasting at least 2 weeks.
localized rxn 6cm x 3cm red & swollen;no fever;better by day 3 & 4;
localized reaction; neurological pain; fatigue; This case was reported by a consumer via call center representative and described the occurrence of local reaction in a female patient who received HBV (Engerix B) for prophylaxis.   The patient's past medical history included shingles (had Shingles twice). Concurrent medical conditions included shellfish allergy.   On an unknown date, the patient received the 1st dose of Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced local reaction, nerve pain and fatigue. On an unknown date, the outcome of the local reaction, nerve pain and fatigue were unknown.   It was unknown if the reporter considered the local reaction, nerve pain and fatigue to be related to Engerix B.  Additional details were provided as follows: This case was reported by patient herself. The age at vaccination was not reported. The patient developed an adverse reaction localized reaction, neurological pain and fatigue.  The patient also mentioned she wanted to receive Shingrix, but she did not know if she can because she was allergic to Shellfish.  The patient also believes that she developed adverse reactions after Engerix-B due to this allergy.
Left shoulder ache, redness, heat to touch, rash - Pt. seen in office 8/19/10.
Client with history of keloid scars, well educated about benefits and risk intradermal monkeypox vaccine, and per client preference  to receive vaccine, it was given on left forearm intradermally.  Client was also educated and information  provided how to report any adverse reaction related to monkeypox pox  vaccine, and client verbalized understanding.
patient received their second prevnar 20 in two months. received their pcv 20  on 5/1 and received second pcv 20 on 5/20. patient called and was complaining of headache and body aches.
I just got home from work, I started feeling weak.  I started shaking, then I started coughing and choking.  I then vomited, I took a shower then laid down.  I had really bad gerd!!!!! I stayed in bed all evening, I had a hard time making it to the bathroom to pee, I would start peeing before I could make it to the bathroom. The next day I stayed in bed all day, I called the doctor on call and he said to take two Prilosec and Benadryl daily.  I'm slowly starting to feel better, the gerd is not as bad, still have some stomache pain-gas.
autoimmune inner ear disease; hearing loss; dizziness; This literature-study case was reported in a literature article and describes the occurrence of AUTOIMMUNE INNER EAR DISEASE (autoimmune inner ear disease) and DEAFNESS (hearing loss) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autoimmune inner ear disease (5 plus years of duration).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AUTOIMMUNE INNER EAR DISEASE (autoimmune inner ear disease) (seriousness criterion medically significant), DEAFNESS (hearing loss) (seriousness criterion medically significant) and DIZZINESS (dizziness). At the time of the report, AUTOIMMUNE INNER EAR DISEASE (autoimmune inner ear disease), DEAFNESS (hearing loss) and DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered AUTOIMMUNE INNER EAR DISEASE (autoimmune inner ear disease), DEAFNESS (hearing loss) and DIZZINESS (dizziness) to be possibly related.    Concomitant product use was not provided by the reporter.   Treatment information was not provided.  Patient had Hearing loss and Dizziness as symptoms.  Company Comment: A 74-year-old female, with concurrent autoimmune inner ear disease, presented with serious unexpected events of autoimmune inner ear disease with hearing loss and dizziness. Event latency 7 days after first dose. Event outcome not reported. Rechallenge unknown. Reporter causality assessed as possibly related. Causality possible from temporal association. Event consistent with known immunomodulation effect of mRNA-1273. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2021-337994, MOD-2021-337995, MOD-2021-337996, MOD-2021-337997, MOD-2021-337998, MOD-2021-337999, MOD-2021-338000, MOD-2021-338001, MOD-2021-338002, MOD-2021-338003, MOD-2021-338004, MOD-2021-338005, MOD-2021-338006, MOD-2021-338007, MOD-2021-338008, MOD-2021-338009, MOD-2021-338010.; Sender's Comments: A 74-year-old female, with concurrent autoimmune inner ear disease, presented with serious unexpected events of autoimmune inner ear disease with hearing loss and dizziness. Event latency 7 days after first dose. Event outcome not reported. Rechallenge unknown. Reporter causality assessed as possibly related. Causality possible from temporal association. Event consistent with known immunomodulation effect of mRNA-1273. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Redness and swelling around injection site about the size of 1/2 dollar. Advised cool compress, Tylenol as needed. Call back if symptoms increase.
Baby has been walking for weeks now. Suddenly refusing to stand or walk. Cries when I try to stand him on his feet. Decreased appetite and low grade fever 100.0F.
RECEIVED HALF DOSE FOR BOOSTER; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 36 year old female of unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. On an unspecified date, the patient previously received covid-19 vaccine ad26.cov2.s vaccination from an unspecified manufacturer (suspension for injection, route of admin not reported, batch number: unknown expiry: UNKNOWN) dose was not reported, 1 in total, (dose number in series: 1) for prophylactic vaccination and it was unknown whether patient had any adverse events. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809 or 211A21A expiry: UNKNOWN) dose of 0.25 milliliters, 1 in total, (dose number in series: 2), administered on 27-NOV-2021 for prophylactic vaccination (RRT: Received half dose for booster, LLT: vaccine underdose, and Off label use). No concomitant medications were reported.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the received half dose for booster and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211202250, 20211201046, 20211202193, 20211201228, 20211200717, 20211200723, 20211200752, 20211200769, 20211200994, 20211201179, 20211201304, 20211201351, 20211201362, 20211201392, 20211201443, 20211201450, 20211201963, 20211202161, 20211202199, 20211202207, 20211202246, 20211202371, 20211202379, 20211202469, 20211204104, 20211220152, 20211220146, 20211220262, 20211220145, 20211220619 and 20211220155.
Information has been received from a female patient of unknown age concerning herself. On 07-JAN-2015, the patient was vaccinated with her first and only dose of VARIVAX (Merck) (strength not reported, 1 dose, injection). On 21-JAN-2015, 14 days after receiving VARIVAX (Merck), the patient developed spots all over her body, including the injection site, with the largest spots on her face. Patient also said that she felt a full body ache. There was valacyclovir hydrochloride given as treatment for the adverse events. The patient went to see unspecified health care professional (HCP) for medical attention. The patients said most of the spots had crusted over. Outcome of the full body ache was unknown. Causality between the adverse events and VARIVAX (Merck) was unknown. Additional information is not expected since no contact information provided.
I'm not all sure this is related to the covid vaccine.  On Oct 19, 200 (about 6 weeks after the last covid vaccine dose) I had a total hip replacement at local Hospital.  Surgery went well, but immediately post-op, I was extremely nausea for hours and vomited repeatedly.  I was given meds to manage it and discharged the next day on pain medications.  On Oct 21, 2022 my husband was diagnosed with a blood clot in his left leg and was admitted to the ER.  I could not help because I was recovering from own extensive surgery.  On Oct 22, 2022, I woke with a racing heart, light-headness, dizziness, and feeling weak.  My sister took me to the ER at Medical Center where I was diagnosed with atrial fibrillation.  I was hospitalized for three days to get heart rhythm under control.  I have been in normal sinus rhythm since then.  I reported vaccine status to doctors if asked, but other than that, there was no discussion about it.
I had a mild reaction to the vaccines both times.  I am now reporting that I have developed Shingles for the first time,  My symptoms began on 4/16/21.  I was diagnoses as having shingles on 4/20/21.  I researched shingles and Covid and found that Israel has reported several post vaccine cases of shingles.  Thus I am reporting my own condition to determine if there is a causal relationship.
body aches, headache, fever, pain in underarm area and groin area, rash and swelling on arm, fatigue
redness, swelling, and a large lump within a couple of hours after the vaccination. Pt later developed vomiting & diarrhea that day & was sick for several days afterwards
epididymitis; testicle pain; This spontaneous case was reported by a consumer and describes the occurrence of EPIDIDYMITIS (epididymitis) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Dec-2020, the patient experienced TESTICULAR PAIN (testicle pain). On an unknown date, the patient experienced EPIDIDYMITIS (epididymitis) (seriousness criterion medically significant). At the time of the report, EPIDIDYMITIS (epididymitis) and TESTICULAR PAIN (testicle pain) outcome was unknown. Not Provided          Event occurred after patient received the fist dose of mRNA-1273  vaccine.  No concomitant product was reported.  Treatment drug include Antibiotics , pain killers, Gabapentin, Tramadol, Hydrocodone, Celebrex.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   This case was linked to MODERNATX, INC.-MOD-2021-076180 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded. MODERNATX, INC.-MOD-2021-076180:CROSSLINKED WITH DOSE 2
Immediately got a headache. I mean immediately. Then light headed ness/dizziness. By 15 mines I thought it had gone away so I left but by the time I got to my car I realized I was dizzy again. 10 minutes later I got home still dizzy and my throat and mouth were going numb and tingling. I took a nap bc I was tired.  3 hours later I was itchy all over, light headed, dizzy, and the tingly and numbness was all over my face, mouth, and throat. All the symptoms came and went. I went to the er and they didn?t want me to say allergic reaction and gave me steroids and anxiety medication even though I was not anxious.
Gave too low of a dose. (Underused the patient) Gave the 6 year old 0.25ml instead of 0.5ml Pt had no side effects from vaccine.
Shoulder injury related to vaccine administration. Injection was given too high or deep into shoulder. I was unable to lift my arm normally within  hours of vaccine administration.  Pain and stiffness continued at a high level for weeks. Pain in shoulder continues today. Diagnosis came from orthopedic surgeon.
Shingles; This spontaneous case was reported by a pharmacist and describes the occurrence of HERPES ZOSTER (Shingles) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with METHYLPREDNISOLONE at an unspecified dose and frequency and TRAMADOL at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were reported.  Pharmacist reported AE on behalf of patient who got Shingles after 1st dose of Moderna Vaccine. Consent obtained for safety follow up. Phone is the preferred method. Reporter mentioned that Potential AE for 2nd dose, contracted shingles antiviral medicine, should we give him 2nd dose.
Lethargic; Fever of 100.2 within 4 hours; Loss of appetite; Headache; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 28Apr2021 at 07:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had known allergies which were unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medication within two weeks of COVID-19 vaccine. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 07Apr2021 at 07:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 12:30, the patient experienced fever of 100.2 within four hours, headache, lethargic, loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL. On 28Apr2021, the patient underwent Body Temperature and the result was 100.2 (UNSPECIFIED UNITS). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 100.2 within four hours, headache, lethargic, loss of appetite was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected
Localized swelling, itching, redness. Tx ice, BENADRYL.
Woke up early at around 7am feeling itchy, but there was no visible reaction such as rash or a hives or a rash. About 30 minutes later I was having issues taking deep breaths which led to difficulty breathing entirely. Got dressed in about 5 minutes and alerted my father that I needed to go to the hospital because of the breathing difficulty. We arrived at the hospital close to 8am where I was taken back within 2 minutes. Standard bloodwork was ran and I was given a prescription for diphenhydrAMINE 25mg CAP, FAMOTIDINE 40mg TAB, predniSONE 20mg TAB, and an Epipen; as they thought I was having an allergic reaction. Was discharged the same day at roughly 10:40 am
This spontaneous report was received from a registered nurse via Poison & Drug Center and refers to a 12 month old male patient. The patient's relevant medical history included candidal diaper rash and "no active problems". On 28-NOV-2016, the patient was vaccinated with a dose of VARIVAX, 0.5 ml, subcutaneously, once, lot # reported as M028546, expiration date 07-JUN-2016 (anatomical location was not reported), for routine health care. The dose of vaccine had undergone a temperature excursion on an unknown date. The patient's concomitant medications included nystatin cream started on 23-NOV-2016 for candidal diaper rash. The patient's laboratory values included a point of care hemoglobin of 10.3 (units not provided) on 28-NOV-2016. The patient did not experience an adverse reaction and no treatments were provided. At the time of the report, it was unknown if the patient continued to receive VARIVAX. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA000108: US-009507513-1612USA000002.
Dizzy. Headache; rapid heart beat; itchy neck area; slight fever; lasted about 12 hrs.
Numbness and tingling in left arm; Numbness and tingling in left arm; Strong pain in left forearm; Feels like she had hit her funny-bone and the effect was lasting quite a while.; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL1283) via an unspecified route of administration on the left arm on 14Jan2021 15:30 at single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. There were no concomitant medications. No other vaccine in four weeks. The patient had no COVID prior vaccination. The patient had not COVID tested post vaccination. The patient experienced numbness and tingling in left arm, strong pain in left forearm, feels like she had hit her funny-bone and the effect was lasting quite a while, all on 14Jan2021 17:00. Next day, still tingling and numbness in left arm. No treatment received for the events. The outcome of the events was not recovered.
Information has been received from a health professional concerning a 27 month old healthy male who on 08/13/2003 was vaccinated with a dose of varicella virus vaccine live.  Concomitant vaccines on 08/13/2003 included poliovirus vaccine, measles-mumps-rubella vaccine and pneumococcal conj vaccine.  On 11/13/2004 the patient broke in a rash with less than 50 pox and had slight vomiting.  The patient was afebrile.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information has been requested.